IDEXX Laboratories, Inc. (IDXX) Stock Delivers 97% Return in 3 Years, Outpacing Zoetis and Market

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. IDEXX Laboratories, Inc. is one of them.

IDEXX Laboratories, Inc. (NASDAQ:IDXX) specializes in animal health diagnostics, veterinary software, and laboratory services, supporting companion animals, livestock, water testing, and food safety worldwide. Its platforms, including imaging systems, in-clinic analyzers, and point-of-care tools, enable veterinarians to quickly diagnose and treat a wide range of conditions.

In August 2025, IDXX reported impressive Q2 earnings, with revenue of $1.11 billion, a 10.6% year-over-year increase, and earnings per share rising to $3.63, far exceeding market expectations. These results prompted the business to raise its full-year revenue and profit forecasts, reflecting continued momentum in diagnostics and laboratory services.

A key growth driver has been the rollout of the inVue Dx analyzer, a rapid blood and ear canal diagnostic device. Roughly 2,400 units were installed in Q2, prompting an upward revision of the full-year installation target to 5,500 units. This launch strengthens IDXX’s leadership in point-of-care veterinary testing and supports accelerating organic growth.

Analysts now project 2025 earnings per share between $12.40 and $12.76, reflecting expanding margins and strong operational performance. Over the past three years, IDEXX Laboratories, Inc. (NASDAQ:IDXX) shares have returned 97%, significantly outperforming competitors such as Zoetis and the broader market, highlighting its position as a top-performing stock in the animal health sector.

While we acknowledge the potential of IDXX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.